Regionally selective activation and differential regulation of ERK, JNK and p38 MAP kinase signalling pathway by protein kinase C in mood modulation

International Journal of Neuropsychopharmacology

Volumn 15, Issue 6, 2012, Pages 781-793

  Galeotti, Nicoletta ^a   Ghelardini, Carla ^a  

^a Department of Preclinical and Clinical Pharmacology ^*  (Italy)

Author keywords

Antidepressant; depression; forced swim test; MAPK; protein kinase C; tail suspension test

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTIDEPRESSANT AGENT; CALPHOSTIN C; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE C; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; FORCED SWIMMING TEST; FRONTAL CORTEX; IMMUNOBLOTTING; MALE; MOOD DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TAIL FLICK TEST;

AFFECT; ANALYSIS OF VARIANCE; ANIMALS; CREB-BINDING PROTEIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HINDLIMB SUSPENSION; MALE; MAP KINASE KINASE 4; MAP KINASE SIGNALING SYSTEM; MICE; MOTOR ACTIVITY; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN ISOFORMS; PROTEIN KINASE C; SWIMMING;

EID: 84862134406     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711000897     Document Type: Article

References (53)

1. Ahi J, Radulovic J, Spiess J (2004). The role of hippocampal signaling cascades in consolidation of fear memory. Behavioural Brain Research 149, 17-31. (Pubitemid 38096363)
2. Alessandrini A, Namura S, Moskowitz MA, Bonventre JV (1999). MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proceedings of the National Academy of Sciences USA 96, 12866-12869. (Pubitemid 29513594)
3. Bhat RV, Engber TM, Finn JP, Koury EJ, et al. (1998). Region-specific targets of p42/p44MAPK signaling in rat brain. Journal of Neurochemistry 70, 558-571. (Pubitemid 28079345)
4. Blendy JA (2006). The role of CREB in depression and antidepressant treatment. Biological Psychiatry 59, 1144-1150.
5. Bravo JA, Diaz-Veliz G, Mora S, Ulloa JL, et al. (2009). Desipramine prevents stress-induced changes in depressive-like behavior and hippocampal markers of neuroprotection. Behavioural Pharmacology 20, 273-285.
6. Bremner JD (2002). Structural changes in the brain in depression and relationship to symptom recurrence. CNS Spectrum 7, 135-139.
7. Briand LA, Blendy JA (2010). Molecular and genetic substrates linking stress ad addiction. Brain Research 1314, 219-234.
8. Chen AC-H, Shirayama Y, Shin K-H, Neve RL, Duman RS (2001). Expression of the cAMP Response Element Binding Protein (CREB) in hippocampus produces an antidepressant effect. Biological Psychiatry 49, 753-762. (Pubitemid 32452296)
9. Crews CM, Erikson RL (1992). Purification of a murine protein-tyrosine/threonine kinase that phosphorylates and activates the erk-1 gene product: relationship to the fission yeast byr1 gene product. Proceedings of the National Academy of Sciences USA 89, 8205-8209.
10. Cryan JF, Mombereau C, Vassout A (2005). The tail suspension as a model for assessing antidepressant activity : review of pharmacological and genetic studies in mice. Neuroscience and Biobehavioral Reviews 29, 571-625. (Pubitemid 40755457)
11. Dong C, Davis RJ, Flavell RA (2002). Cytokine profiling and chemical allergy. Annual Reviews of Immunology 20, 55-72.
12. Drevets WC, Price JL, Simpson JR, Todd RD, et al. (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386, 824-827. (Pubitemid 27181254)
13. Duman CH, Schlesinger L, Kodama M, Russel DS, et al. (2007). A role for MAP kinase signaling in behavioural models of depression and antidepressant treatment. Biological Psychiatry 61, 661-670. (Pubitemid 46328865)
14. Dwivedi Y, Rao JS, Rizavi HS, Kotowski J, Conley RR, et al. (2003). Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Archives of General Psychiatry 60, 273-282. (Pubitemid 36307438)
15. Einat H, Yuan PX, Gould TD, Li JL, et al. (2003). The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. Journal of Neuroscience 23, 7311-7316. (Pubitemid 36999520)
16. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, et al. (1998). Identification of a novel inhibitor of mitogenactivated protein kinase kinase. Journal of Biological Chemistry 273, 18623-18632. (Pubitemid 28334795)
17. Flood DG, Finn JP, Walton KM, Dionne CA, et al. (1998). Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinase MEK1 and MEK4, in adult rat central nervous system. Journal of Comparative Neurology 398, 373-392. (Pubitemid 28360041)
18. Friedman E, Wang Hoau-Yan, Levinson D, Connell TA, et al. (1993). Altered platelet protein kinase C activity in bipolar affective disorders, manic episode. Biological Psychiatry 33, 520-525. (Pubitemid 23167218)
19. Fumagalli F, Molteni R, Calabrese F, Frasca A, et al. (2005). Chronic fluoxetine administration inhibits extracellular signal-related kinase 1/2 phosphorylation in rat brain. Journal of Neurochemistry 93, 1551-1560. (Pubitemid 40853278)
20. Galeotti N, Bartolini A, Ghelardini C (2003). The phospholipase C-IP3 pathway is involved in muscarinic antinociception. Neuropsychopharmacology 28, 888-897.
21. Garcia R (2002). Stress, synaptic plasticity, and psychopathology. Reviews in the Neurosciences 13, 195-208. (Pubitemid 35178152)
22. Gioia M, Galbiati S, Rigamonti L, Moscheni C, et al. (2001). Extracellular signaling-regulated kinases1 and 2 phosphorylated neurons in the tele-and diencephalons of rat after visceral pain stimulation: an immunocytochemical study. Neuroscience Letters 308, 177-180. (Pubitemid 32710152)
23. Grammer TC, Blenis J (1997). Evidence for MEKindependent pathways regulating the proplonged activation of ERK-MAP kinases. Oncogene 14, 1635-1642. (Pubitemid 27198935)
24. Houslay MD, Kolch W (2000). Cell-type specific integration of cross-talk between extracellular signal-regulated kinases and camp signaling. Molecular Pharmacology 58, 659-668.
25. Johnson GL, Lapadat R (2002). Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912. (Pubitemid 35425238)
26. Johnson GL, Nakamura K (2007). The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochimica et Biophysica Acta 1773, 1341-1348. (Pubitemid 47125977)
27. Karege F, Bovier P, Rudolph W, Gaillard JM (1996). Platelet phosphoinositide signaling system: an overstimulated pathway in depression. Biological Psychiatry 39, 679-702.
28. Kendler KS, Thornton LM, Gardner CO (2001). Genetic risk, number of previous depressive episodes, and stressful life events in predicting onset of major depression. American Journal of Psychiatry 158, 582-586. (Pubitemid 32289820)
29. Kinkl N, Sahel J, Hicks D (2001). Alternate FGF2-ERK1/2 signaling pathways in retinal photoreceptor and glial cells invitro. Journal of Biological Chemistry 276, 43871-43878.
30. Liu YF, Bertram K, Perides G, McEwen BS, et al. (2004). Stress induces activation of stress-activated kinases in the mouse brain. Journal of Neurochemistry 89, 1034-1043. (Pubitemid 38684748)
31. Manier DH, Shelton RC, Sulser F (2002). Noradrenergic antidepressants : does chronic treatment increrase or decrease nuclear CREB-P? Journal of Neural Transmission 109, 91-99. (Pubitemid 34146592)
32. Mombereau C, Gur TL, Onksen J, Blendy JA (2010). Differential effects of acute and repeated citalopram in mouse models of anxiety and depression. International Journal of Neuropsychopharmacology 13, 321-334.
33. Murray B, Alessandrini A, Cole AJ, Yee AG, et al. (1998). Inhibition of the p44/42 MAP kinase pathway protects hippocampal neurons in a cell-culture model of seizure activity. Proceedings of the National Academy of Sciences USA 95, 11975-11980. (Pubitemid 28460524)
34. Nishima H, Bachmann M, Oliveira-dos-Santos AJ, Kozieradzki I, et al. (1997). Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase 4 (MKK4)-deficient T lymphocytes. Journal of Experimental Medicine 186, 941-953. (Pubitemid 27407355)
35. Nishizuka Y (1992). Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607-615.
36. Oh SW, Ahn YM, Kang UG, Kim YS, et al. (1999). Differential activation of c-Jun N-terminal protein kinase and p38 in rat hippocampus and cerebellum after electroconvulsive shock. Neuroscience Letters 271, 101-104. (Pubitemid 29400677)
37. Pandey GN, Dwivedi Y, Kumari R, Janicak PG (1998). Protein kinase C in platelets of depressed patients. Biological Psychiatry 44, 909-911. (Pubitemid 28520229)
38. Porsolt RD, Bertin A, Jalfre M (1977). Behavioural despair in mice: A primary screening test for antidepressants. Archives Internationales de Pharmacodynamie 229, 327-336. (Pubitemid 8225714)
39. Post RM (1992). Transduction of psychosocial stress into the neurobiology of recurrent affective disorders. American Journal of Psychiatry 149, 999-1010.
40. Pouyssegur J, Volmat V, Lenormand P (2002). Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling. Biochemical Pharmacology 64, 755-763. (Pubitemid 35238027)
41. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki JR (1991). Phosphorylation of c-jun mediated by MAP kinases. Nature 353, 670-674. (Pubitemid 21912588)
42. Ren X, Dwivedi Y, Mondal AC, Pandey GN (2011). Cyclic-AMP response element binding protein (CREB) in the neutrophils of depressed patients. Psychiatry Research 185, 108-112.
43. Robertson ED, English JD, Adams JP, Selcher JC, et al. (1999). The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. Journal of Neuroscience 19, 4337-4348. (Pubitemid 29241087)
44. Robinson MJ, Cobb MH (1997). Mitogen-activated protein kinase pathways. Current Opinion in Cell Biology 9, 180-186. (Pubitemid 27135985)
45. Schroeter H, Boyd CS, Ahmed R, Spencer JP, et al. (2003). JNK-mediated modulation of brain mitochondriadependent apoptosis. Biochemistry Journal 372, 359-369.
46. Sweatt JD (2001). The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. Journal of Neurochemistry 76, 1-10.
47. Todorovic C, Sherrin T, Pitts M, Hippel C, et al. (2009). Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF2-deficient mice. Neuropsychopharmacology 34, 1416-1426.
48. Tronson NC, Schrick C, Fischer A, Sananbenesi F, et al. (2008). Regulatory mechanisms of fear extinction and depression-like behavior. Neuropsychopharmacology 33, 1570-1583. (Pubitemid 351684712)
49. Walton KM, Di Rocco R, Bartlett BS, Koury E, et al. (1998). Activation of p38MAPK in microglia after ischemia. Journal of Neurochemistry 70, 1764-1767.
50. Wang HY, Markowitz P, Levinson D, Undie AS, et al. (1999). Increased membrane associated protein kinase C activity and translocation in blood platelets from bipolar affective disorders patients. Journal of Psychiatry Research 33, 171-179. (Pubitemid 29134745)
51. Ward NL, Hagg T (2000). SEK1/MKK4, c-Jun and NFkB are differentially activated in forebrain neurons during postnatal development and injury in both control and p57NGFR-deficient mice. European Journal of Neuroscience 12, 1867-1888.
52. Yamada S, Yamamoto M, Ozawa H, Riederer P, et al. (2003). Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorders. Journal of Neural Transmission 110, 671-680. (Pubitemid 36683520)
53. Yuan LL, Adams JP, Swank M, Sweatt JD, et al. (2002). Protein kinase modulation of dendritic K+ channels in hippocampus involves a mitogen-activated protein kinase pathway. Journal of Neuroscience 22, 4860-4868. (Pubitemid 37465601)